CBD Life Sciences (OTCMKTS:CBDL) Stock In Focus: Company Introduces Delta-8 and Delta-9 Infused Gummies
CBD Life Sciences (OTCMKTS: CBDL), via its wholly owned subsidiary LBC Bioscience Inc., announced on August 18, 2022, about introducing a product that is infused with both Delta-8 & Delta-9. These yummy, apple-flavored gummies contain 15MG of Delta-8 & 10MG of Delta-9 per gummy and will come in a 15-Count Jar. Trading Data On Thursday, CBDL stock ended flat at $0.0002 with more than 78.84 million shares, compared to its…